期刊文献+

血液透析患者钙磷紊乱的调查 被引量:3

Clinical investigation on calcium and phosphorus disturbance in hemodialysis patients
下载PDF
导出
摘要 目的:了解血液透析患者骨代谢和骨病控制情况。方法:对我院血液净化中心血液透析的92例患者骨代谢指标进行调查,并与国际肾脏病基金会慢性透析患者骨代谢和骨病控制指南进行比较。结果:92例中,有84例(91.05%)血清钙浓度、42例(45.36%)磷浓度、60例(67.2%)钙磷乘积、65例(59.79%)PTH达到K/DOQI所要求的目标,但仅有20例(占21.7%)患者所有指标均达到要求目标。结论:多数血液透析患者骨代谢和骨病控制仍然不能达到K/DOQI要求的目标。 Objective:To understand the bone metablism and the controling situation of the bony disease. Methods: Laboratory parameters of bone and mineral metabolism were investigated in 92 patients in hemodialysis centre of our hospital and compared with the bone metabolism and guideine of bony disease in chronic hemodialysis patient. Results: The levels of serum calcium and serum phosphorus fell within the range reccmmended by the K/DOQI guidelines 91.05%and45.36%of the time respectively. 67.2%of the determinations for calcium' phosphorus product was〈55m^2/dl^2. PTH levels were within the recommended values in 59.79%ofthedeterminations. Only 21.7%of the determinations met all four criteria. Conclusion: The bone metablism and the control of the bony disease in most hemodialytie patients still cannot reach the K/DOQI guidelines.
出处 《温州医学院学报》 CAS 2006年第6期536-538,共3页 Journal of Wenzhou Medical College
关键词 肾透析 甲状旁腺功能亢进症 继发 钙代谢障碍 磷代谢障碍 kidney, hyperparathyroidism, secondary, calcium metabolism disorder, phosphorus metabolism disorder
  • 相关文献

参考文献14

  • 1Block GA,Hulbert-Shearon TE,Levin NW,et al.Association of serum phosphorus and calcium phosphate product with mortality risk in chronic hemodialysis patients.A national study[J].Am J Kidney DIS,1998,31(4):607-617.
  • 2Block GA,Port FK:Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients.Recommendations for a change in management[J].Am J Kidney DIS 2000;35(6):1226-1237.
  • 3Eknoyan G,Levin A,Levin NW.Bone metabolism and disease in chronic kidney disease[J].Am J Kidney DIS,2003,42(2):197-201.
  • 4Block GA.Prevalence and clinical consequences of elevated.Ca×P product in hemodialysis patients[J].Clin Nephrol,2000,54(4):318-324.
  • 5Levin NW,Hoenich NA,Consequences of hyperphosphatemia and elevated levels of the calcium-phosphorus product in dialysis patients[J].Curr Opin Nephrol Hypertens,2001,10(5):563-568.
  • 6Cannata-Andia JB,Rodriguez-Garcia M.Hyperphosphataemia as a cardiovascular risk factor-How to manage the problem[J].Nephrol Dial Transplant,2002,17(suppl 11):16-19.
  • 7Goodman WG,Goldin J,Kuizon BD,et al.Elashoff RM,Salusky IB:Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis[J].N Engl J MED,2000,342(20):1478-1483.
  • 8Gallieni M,Cozzolino M,Carpani P,et al.Sevelamer reduces calcium load and maintains a low calcium-phosphorus ion product in dialysis patients[J].J Nephrol,2001,14(3):176-183.
  • 9Chertow GM,Burke SK,Dillon MA,et al.Long-term effects of sevelamer hydrochloride on the calcium ! phosphate product and lipid profile of haemodialysis patients[J].Nephrol Dial Transplant,1999,14(12):2907-2914.
  • 10Martin KJ,Gonzalez EA,Gellens M,et al.19-Nor-1-25-dihydroxyvitamin D2 (Paricalcitol) safely and effectively reduces the levels of intact PTH in patients on hemodialysis[J].J Am Soc Nephro,1998,9(8):1427-1432.

同被引文献30

  • 1王兰,全蕾,骆素萍,甘红兵,汪涛.健康教育对腹透病人依从性的影响[J].中华护理杂志,2004,39(4):289-290. 被引量:39
  • 2马璐璐,刘毅,王刚.健康宣教对维持性透析患者钙磷的影响[J].中国实用护理杂志(下旬版),2005,21(2):58-59. 被引量:23
  • 3孙鲁英,王梅,杨莉.终末期肾脏病患者钙磷代谢及甲状旁腺激素水平的临床分析[J].北京大学学报(医学版),2005,37(2):147-150. 被引量:63
  • 4张路霞,王梅,王海燕.慢性肾脏病的流行病学研究[J].中华肾脏病杂志,2005,21(7):425-428. 被引量:69
  • 5Block GA,Port FK.Re-eraluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients.Recommendations for a change in management.Kidney KIS,2000,35(6):1226-1237.
  • 6Eknoyan G,Levin A,Levin NW.Bone metabolism and disease in chronic kidney disease.Kidney DIS,2003,42 (2):197-201.
  • 7Block GA,Hulbert-Shearon TE,Levin NW,et al.Association of serum phosphorus and calcium phosphate product with mortality risk in chronic hemodialysis patients.A national study.Kidney DIS,1998,31 (4):607-617.
  • 8Kim J,Danese S,Satayathum P,et al.Achievement of proposed NKF-K/DOQI bone metabolism and disease guidelines:Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS).Soc Nephrol,2003,14(11):269A-270A.
  • 9Raggi P,Boulay A,Chasan-Taber S,et al.Cardiac calcification in adult hemodialysis patients.A link between endstage renal disease and cardiovascular disease? Coll Cardiol,2002,39 (20):695-701.
  • 10Masho Y,Shigematsu T.Arteriosclerosis and vascular calcification in chronic kidney disease(CKI) patients.Clin Calcium,2007,17(4):354-359.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部